Policy
The invisible cure. Should we be talking more about cancer surgery?
The best chance of being cured of cancer is through surgery by expert surgeons with a deep knowledge of oncology. Why then are the public, patients and policy makers so focused on drugs, and does it matter? Mass media have…
On being a woman in oncology: in their own words
Over the past two decades, Cancer World has had the privilege of publishing profiles of many women who have been leading efforts to improve the quality of cancer care. Coming from all corners of Europe, working in all areas of…
Informal carers play a key role in cancer care: they need and deserve more support
What is it worth to patients to have someone they can rely on to provide emotional support and talk things through, help them get to and from appointments, remind them about what medicines to take and when, help them eat…
North and South ‒ learning faster means learning together
When you look at the vast waiting area in Mumbai’s world leading Tata Memorial Cancer Hospital, pictured above, what do you see? A crowded chaotic scene where sick patients and their relatives sit around for hours, waiting, hoping for someone…
Cancer-related fatigue: Might research into long-Covid help find causes and cures?
Long-term emotionally and physically debilitating fatigue is a fact of daily life for many who have had cancer. Awareness is low, causes mysterious, and physicians are often sceptical or plead powerlessness – even though a growing body of research attests…
Preventing alcohol-related cancers in Europe: lessons from three countries
Alcohol can be bad for your health. Most people know that. But what many people have yet to grasp is that ‒ like smoking tobacco ‒ drinking alcohol can significantly raise their risk of developing and dying from a wide…
Decolonising cancer research: why it matters, what can be done
When cancer epidemiologist and medical doctor Nirmala Bhoo-Pathy returned to Malaysia in 2011 after completing her PhD in cancer epidemiology in the Netherlands, she hadn’t expected the move to negatively affect her research prospects. As it turns out, she was…
Lung cancer screening: time to act on the evidence
“It’s extraordinary that screening for the biggest cancer killer is not available in most of Europe," says Anne Marie Baird, President of Lung Cancer Europe (LuCE). “Lung cancer causes more deaths in Europe than breast, colorectal and cervical cancers combined,…
Trust me: I’m a surgical oncologist!
Surgery has been the mainstay for treating solid tumours since the dawn of cancer treatment, and recent decades have seen a huge increase in the complexity and multidisciplinary demands of carrying out cancer operations. So it can come as a…
PSA population screening is back in favour: here’s why
Five years ago, the idea of national screening programmes for prostate cancer had gone cold. The benefits of PSA (prostate specific antigen) blood testing, introduced as a screening tool in the 1980s, had long been fiercely debated. But by 2015…